Antinociceptive effects of butorphanol, buprenorphine, or both, administered intramuscularly in cats

American Journal of Veterinary Research

Volumn 68, Issue 7, 2007, Pages 699-703

  Johnson, Jacob A ^a   Roberston, Sheilah A ^a   Pypendop, Bruno H ^b  

^a University of Florida College of Veterinary Medicine   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; BUTORPHANOL; BUTORPHANOL TARTRATE; OPIATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CAT; CONTROLLED STUDY; FEMALE; HEAT SENSITIVITY; INDIVIDUALIZATION; MALE; NONHUMAN; SKIN TEMPERATURE; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE;

ANALGESICS, OPIOID; ANIMALS; BUPRENORPHINE; BUTORPHANOL; CATS; CROSS-OVER STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HEAT; INJECTIONS, INTRAMUSCULAR; MALE; NOCICEPTORS; PAIN MEASUREMENT; SKIN TEMPERATURE;

ANIMALIA; FELIS CATUS;

EID: 34547466650     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.68.7.699     Document Type: Article

References (41)

1. Hansen B, Hardie E. Prescription and use of analgesics in dogs and cats in a veterinary teaching hospital: 258 cases (1983-1989). J Am Vet Med Assoc 1993;202:1485-1494.
2. Hewson CJ, Dohoo IR, Lemke KA. Perioperative use of analgesics in dogs and cats by Canadian veterinarians in 2001. Can Vet J 2006;47:352-359.
3. Wagner AE. Is butorphanol analgesic in dogs and cats? Vet Med 1999;94:346-350.
4. Metz S, Headley R, Star R, et al. I'm confused about using butorphanol and buprenorphine together. Vet-to-Vet: Anesthesia/Analgesia. Veterinary Information Network. Available at: www.vin.com. Accessed Jun 14, 2006.
5. Robertson SA, Taylor PM, Lascelles BD, et al. Changes in thermal threshold response in eight cats after administration of buprenorphine, butorphanol and morphine. Vet Rec 2003;153:462-465.
6. Hoskin PJ, Hanks GW. Opioid agonist-antagonist drugs in acute and chronic pain states. Drugs 1991;41:326-344.
7. Cowan A. Update on the general pharmacology of buprenorphine. In: Cowan A, Lewis JW eds. Buprenorphine: combating drug abuse with a unique opioid. New York: Wiley-Liss, 1995;31-47.
8. Dixon MJ, Robertson SA, Taylor PM. A thermal threshold testing device for evaluation of analgesics in cats. Res Vet Sci 2002;72:205-210.
9. Lascelles BD, Robertson SA. Antinociceptive effects of hydromorphone, butorphanol, or the combination in cats. J Vet Intern Med 2004;18:190-195.
10. Lascelles BD, Robertson SA. Use of thermal threshold response to evaluate the antinociceptive effects of butorphanol in cats. Am J Vet Res 2004;65:1085-1089.
11. Gaver RC, Vasiljev M, Wong H, et al. Disposition of parenteral butorphanol in man. Drug Metab Dispos 1980;8:230-235.
12. Carroll GL, Boothe DM, Hartsfield SM, et al. Pharmacokinetics and pharmacodynamics of butorphanol in llamas after intravenous and intramuscular administration. J Am Vet Med Assoc 2001;219:1263-1267.
13. Pfeffer M, Smyth RD, Pittman KA, et al. Pharmacokinetics of subcutaneous and intramuscular butorphanol in dogs. J Pharm Sci 1980; 69:801-803.
14. Sawyer DC, Rech RH. Analgesia and behavioral effects of butorphanol, nalbuphine, and pentazocine in the cat. J Am Anim Hosp Assoc 1987;23:438-446.
15. Sawyer DC, Rech RH, Durham RA, et al. Dose response to butorphanol administered subcutaneously to increase visceral nociceptive threshold in dogs. Am J Vet Res 1991;52:1826-1830.
16. Kalpravidh M, Lumb WV, Wright M, et al. Analgesic effects of butorphanol in horses: dose-response studies. Am J Vet Res 1984;45:211-216.
17. Kalpravidh M, Lumb WV, Wright M, et al. Effects of butorphanol, flunixin, levorphanol, morphine, and xylazine in ponies. Am J Vet Res 1984;45:217-223.
18. Muir WW, Robertson JT. Visceral analgesia: effects of xylazine, butorphanol, meperidine, and pentazocine in horses. Am J Vet Res 1985;46:2081-2084.
19. Waterman AE, Livingston A, Amin A. Analgesic activity and respiratory effects of butorphanol in sheep. Res Vet Sci 1991;51:19-23.
20. Robertson SA, Lascelles BD, Taylor PM, et al. PK-PD modeling of buprenorphine in cats: intravenous and oral transmucosal administration. J Vet Pharmacol Ther 2005;28:453-460.
21. Yassen A, Olofsen E, Dahan A, et al. Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine and fentanyl in rats: role of receptor equilibration kinetics. J Pharmacol Exp Ther 2005;313:1136-1149.
22. Nolan A, Livingston A, Waterman AE. Investigation of the antinociceptive activity of buprenorphine in sheep. Br J Pharmacol 1987; 92:527-533.
23. Kest B, Wilson SG, Mogil JS. Sex differences in supraspinal morphine analgesia are dependent on genotype. J Pharmacol Exp Ther 1999;289:1370-1375.
24. Mogil JS. The genetic mediation of individual differences in sensitivity to pain and its inhibition. Proc Natl Acad Sci U S A 1999;96:7744-7751.
25. Mogil JS, Chesler EJ, Wilson SG, et al. Sex differences in thermal nociception and morphine antinociception in rodents depend on genotype. Neurosci Biobehav Rev 2000;24:375-389.
26. Mogil JS, Ritchie J, Smith SB, et al. Melanocortin-1 receptor gene variants affect pain and mu-opioid analgesia in mice and humans. J Med Genet 2005;42:583-587.
27. Mogil JS, Wilson SG, Chesler EJ, et al. The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans. Proc Natl Acad Sci U S A 2003;100:4867-4872.
28. Wilson SG, Smith SB, Chesler EJ, et al. The heritability of antinociception: common pharmacogenetic mediation of five neurochemically distinct analgesics. J Pharmacol Exp Ther 2003;304:547-559.
29. Barrett AC, Cook CD, Terner JM, et al. Sex and rat strain determine sensitivity to kappa opioid-induced antinociception. Psychopharmacology (Berl) 2002;160:170-181.
30. Barrett AC, Smith ES, Picker MJ. Sex-related differences in mechanical nociception and antinociception produced by mu- and kappa-opioid receptor agonists in rats. Eur J Pharmacol 2002;452:163-173.
31. Pick CG, Cheng J, Paul D, et al. Genetic influences in opioid analgesic sensitivity in mice. Brain Res 1991;566:295-298.
32. Cicero TJ, Nock B, Meyer ER. Gender-related differences in the antinociceptive properties of morphine. J Pharmacol Exp Ther 1996;279:767-773.
33. Craft RM, Bernal SA. Sex differences in opioid antinociception: kappa and 'mixed action' agonists. Drug Alcohol Depend 2001;63:215-228.
34. Negus SS, Mello NK. Opioid antinociception in ovariectomized monkeys: comparison with antinociception in males and effects of estradiol replacement. J Pharmacol Exp Ther 1999;290:1132-1140.
35. Cook CD, Barrett AC, Roach EL, et al. Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor. Psychopharmacology (Berl) 2000;150:430-442.
36. Terner JM, Barrett AC, Cook CD, et al. Sex differences in (-)-pentazocine antinociception: comparison to morphine and spiradoline in four rat strains using a thermal nociceptive assay. Behav Pharmacol 2003;14:77-85.
37. Elmer GI, Pieper JO, Negus SS, et al. Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests. Pain 1998;75:129-140.
38. Lasagna L, Beecher HK. The optimal dose of morphine. J Am Med Assoc 1954;156:230-234.
39. Terner JM, Lomas LM, Smith ES, et al. Pharmacogenetic analysis of sex differences in opioid antinociception in rats. Pain 2003;106:381-391.
40. Lotsch J, Skarke C, Liefhold J, et al. Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives. Clin Pharmacokinet 2004;43:983-1013.
41. Barter LS, Ilkiw JE, Steffey EP, et al. Animal dependence of inhaled anaesthetic requirements in cats. Br J Anaesth 2004;92:275-277.